Baichuan AI
Founded Year
2023Stage
Series A - II | AliveTotal Raised
$1.038BValuation
$0000Last Raised
$687.6M | 1 yr agoMosaic Score The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.
+24 points in the past 30 days
About Baichuan AI
Baichuan AI focuses on professional services in language AI, operating within the artificial intelligence industry. The company's main offerings include a large-scale language model that integrates intent understanding, information retrieval, and reinforcement learning technologies to provide performance in knowledge question-answering and text creation fields. It was founded in 2023 and is based in Haidian, China.
Loading...
Loading...
Research containing Baichuan AI
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Baichuan AI in 4 CB Insights research briefs, most recently on Jan 28, 2025.
Expert Collections containing Baichuan AI
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Baichuan AI is included in 3 Expert Collections, including Generative AI.
Generative AI
2,332 items
Companies working on generative AI applications and infrastructure.
Unicorns- Billion Dollar Startups
1,276 items
Artificial Intelligence
12,337 items
Companies developing artificial intelligence solutions, including cross-industry applications, industry-specific products, and AI infrastructure solutions.
Latest Baichuan AI News
Jul 9, 2025
掉队的百川智能，撑不起王小川的「AI医生梦」 与李世石和AlphaGo的对战不同，这是一场AI明星们和医生团队的集体作战，由豆包、百川、小荷、ChatGPT o3、Google Gemini组成的「AI医疗大模型战队」最终和人类医生团队打了一个平手。 一个「AI医生」的梦似乎从科幻电影里走向现实。 AI医疗不是一门新生意。从发展历程看，从早期医疗信息化到互联网医疗，已挤满了大厂和各路玩家；从技术侧看，从早期如MYCIN等专家系统、应用于医学影像的SVM等传统机器学习算法，再到如今大模型和多模态技术融合发展下，特别是DeepSeek大幅降低了AI医疗的应用门槛，似乎让王小川口中说的「为人类造医生」成为可能。 据机构DataBridge测算，预计到2031年全球AI医疗保健领域市场规模将达到172亿美元，就连OpenAI被曝出的最新神秘项目cderGPT也瞄准这一广阔蓝海。 医疗慢生意和AI快竞争间，王小川时候需要做出抉择了。 一面是传出上市的智谱和MiniMax，一面是凭借着Kimi-Researcher和多模态领域保持一定技术优势的月之暗面和阶跃星辰，和同行们的动作相比，转向医疗领域的百川智能过去一段时间里都低调许多。 就连王小川本人在最新的公开采访中，对百川技术谈的很少，更多的是在对外讲述自己的AI医生梦。在近期和学者赫拉利的一次对谈中，王小川提到一个关于「好医生和坏医生」的判断，他认为，AI医生会比人类医生，会更加善良，工作也更有效。 豪赌AI医生，反映出百川正区别于其他模型独角兽，走上一条另类路径，百川近期一系列「水下」动作也印证了这一趋势。 在模型技术侧，据「蓝鲸新闻」报道，停止预训练新超大规模通用大模型后，百川加速垂类模型的构建。今年1月，百川开源了行业首个医疗增强大模型Baichuan-M1-14B，3月发布了全球首个儿科大模型。 在商业化上，百川一面加大区域市场的拓展，「硅基研究室」了解到，2024年底以来，百川在南京、四川、深圳、海南等地多地设立区域子公司；另一面则是加速自身医疗解决方案在区域当地的落地。 具体到区域打法上，百川实际落地的场景也有所不同——例如在北方区域，百川重点落地的是AI儿科，在北京、河北等地试点构建「AI儿科医生+真人医生」双医模式；在江苏等地，百川目前瞄准的AI精准诊疗，例如和张家港市第一人民医院合作，将百川医疗大模型全面融入肿瘤防治「早筛早诊」等关键环节。 在生态端，百川也在通过对外投资的形式，构建自己的AI医疗圈。百川并购了广州涛喀科技有限公司，投资了小儿方健康科技（北京）有限公司和福棠儿医，涉及医疗用品和互联网医疗领域。 三箭齐发，相比其他AI创企在通用大模型和BC应用两条腿走路，转型医疗这一刚需赛道，百川是沿着王小川「造医生-改路径-促医学」路径似乎找到了更聚焦的方向，但看得见的挑战也摆在眼前。 2、百川的AI医疗，还是新瓶装旧酒 但据他观察，在B端，目前大多数的AI医疗玩家都还在抢占AI入院的「名额」，大模型到底能不能真正落地和赋能临床管理，在「防、筛、诊、治、管」等环节发挥具体实效，都还在进一步摸索。 而百川智能看似在模型技术侧、商业化和生态建设上「三箭齐发」加速在AI医疗建立护城河，但实际落地依旧是「新瓶装旧酒」。 首先，在大模型侧，大模型入院后，不是终点，而是考验百川模型专业化的起点。 当下，已有不下百款医疗大模型落地中国，同时随着大模型加速入院实现本地化部署，医疗大模型从过去的通用性转向聚焦专科专病的专业化。 百川与北京、江苏等医院通过打造儿科、全科等垂类大模型也是如此，本质是「企业+医院」合力，通过入院，百川可以触及更多的垂类医疗数据，提升模型能力，解决实际临床问题。 一位大模型行业人士告诉「硅基研究室」，百川较早切入医疗，而且多模态技术做的也不错，这是其先发优势。 但入院只是开始，收集高质量医疗数据，投喂给大模型，这是一门高成本、高投入的苦活儿和累活儿。 一方面，要看医院的信息化基建水平和医生的配合度。高翔提到，在不少基层医院尽管当下都用上了医疗大模型，但门诊医生的实际使用都很保守。 “门诊那么忙，有的基层医院光门诊一个系统就用了十几年了，太新的交互他们不太容易接受”。高翔坦言，他们不少技术开发人员的主要工作是配合产品经理更新规范手册，给医生做技术培训。 另一方面，医疗数据往往来源多元、模态多样，数据的清洗与标注同样重要，这也给百川等AI创企带来了隐形成本。 其次，在商业化上，AI医疗固然很性感，虽然百川等大模型创企也开辟了「卖API、按Token收费」的商业模式，但在B端还是要走系统集成和定制化的老路。 一方面是医疗合规和数据安全的考量，进入医院的AI医疗项目需要部署到本地机房；另一方面，这些部署项目被包含在医院信息化升级和改造采购中，也意味着市场拓展极其吃政企资源。回到商业模式看，定制化项目最终还是会走上拼续费的老路。 而百川瞄准的儿科和全科，一个是受用药限制，开不了大处方、大检查的细分领域，另一个则是聚焦基层医疗改造的大工程，两条路也都不好走。 而在生态建设上，百川也效仿英伟达、微软等AI巨头通过生态投资，加码自身的医疗版图，但相比英伟达的「卖水人」和微软背后的「云服务、软件组合」优势，现阶段，生态伙伴起到的作用，只能是帮助百川相对轻松地拿下订单。 而从百川的投并购布局上，也不难看出其「商业化的焦虑」——一面是收购医疗用品企业，这意味着后续商业化可以通过卖硬件；另一面，入局互联网医疗企业，本质上还是平台思维，通过拓宽用户规模，为后续商业化如药、保险等提供流量入口。 3、2025，AI医疗「诸神之战」 但短短半年不到，AI医疗正成为巨头抢滩大模型落地的新战场。 在B端，除了实验室科研外，AI大模型已经遍及医疗「防、筛、诊、治、管」等核心场景。 整个AI医疗赛道，颇有「诸神之战」的态势。 一类是平台型企业，是互联网科技浪潮中卷出来的赢家，如微医、医联，优势是不需要重新自建入口。 一类是传统的医疗信息化企业，有垂类数据优势，如润达医疗等。 想要留在AI医疗的牌桌上，等待王小川的无疑是一条更难的路。 该文观点仅代表作者本人，36氪平台仅提供信息存储空间服务。
Baichuan AI Frequently Asked Questions (FAQ)
When was Baichuan AI founded?
Baichuan AI was founded in 2023.
Where is Baichuan AI's headquarters?
Baichuan AI's headquarters is located at Qinghuayuan Street, Haidian.
What is Baichuan AI's latest funding round?
Baichuan AI's latest funding round is Series A - II.
How much did Baichuan AI raise?
Baichuan AI raised a total of $1.038B.
Who are the investors of Baichuan AI?
Investors of Baichuan AI include Tencent, Alibaba Cloud, Xiaomi, Asia Investment Capital, Beijing AI Industry Investment Fund and 8 more.
Who are Baichuan AI's competitors?
Competitors of Baichuan AI include xAI, 01.AI, Sarvam AI, DeepNatural, Rainfe and 7 more.
Loading...
Compare Baichuan AI to Competitors
Inflection AI focuses on enterprise artificial intelligence, providing artificial intelligence (AI) model training and tuning while addressing data security and cost efficiency for enterprise clients. The company's solutions integrate into business operations. It was founded in 2022 and is based in Palo Alto, California.
Aleph Alpha specializes in generative artificial intelligence (AI) technology for enterprises and governments within the artificial intelligence sector. The company offers language models and multimodal AI solutions for human expertise, compliance, and AI applications. Aleph Alpha's technology is tailored for various architectures and value chains. It was founded in 2019 and is based in Heidelberg, Germany.
Anthropic operates a safety and research company focused on developing AI systems. The company's main offerings include Claude, an AI assistant for various tasks, and a suite of research initiatives aimed at AI safety and interpretability. It's research includes natural language processing, human feedback, reinforcement learning, and other areas. It was founded in 2021 and is based in San Francisco, California.
Letta specializes in developing AI agents within the technology sector. The company offers a platform that enables the creation, deployment, and management of AI agents with memory and reasoning capabilities, supported by a visual interface and APIs. Letta serves the artificial intelligence and machine learning industry. It was founded in 2024 and is based in San Francisco, California.
OneGen AI works as a company that provides artificial intelligence (AI) transformation and integration services across various sectors, including banking, finance, healthcare, retail, e-commerce, and automotive. The services include AI application development, AI integration, training, generative AI solutions, predictive analytics, data engineering, and AI assessments. OneGen AI serves startups and enterprises interested in using AI technologies to improve operational efficiency and decision-making. It was founded in 2024 and is based in San Jose, California.
Lila Sciences serves as a technology company focused on scientific advancements within the life, chemical, and materials sciences sectors. The company offers a platform that integrates artificial intelligence with autonomous laboratories to aid in experiment design, conduction, observation, and re-design. Lila Sciences primarily serves sectors that require scientific discovery and innovation, utilizing AI to address challenges in scientific research. It was founded in 2022 and is based in Cambridge, Massachusetts.
Loading...